153 related articles for article (PubMed ID: 25089269)
1. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.
Chen KC; Lee WY; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():429486. PubMed ID: 25089269
[TBL] [Abstract][Full Text] [Related]
2. In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.
Chen KC; Chen KB; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():189495. PubMed ID: 25089263
[TBL] [Abstract][Full Text] [Related]
3. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome.
Chen KC; Lee WY; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():139492. PubMed ID: 25045657
[TBL] [Abstract][Full Text] [Related]
4. In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease.
Chen KB; Chen KC; Chang YL; Chang KL; Chang PC; Chang TT; Chen YC
Molecules; 2016 May; 21(5):. PubMed ID: 27164068
[TBL] [Abstract][Full Text] [Related]
5. Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicine.
Hung TC; Lee WY; Chen KB; Chen CY
Biomed Res Int; 2014; 2014():809816. PubMed ID: 24999477
[TBL] [Abstract][Full Text] [Related]
6. Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer.
Chen KC; Sun MF; Chen HY; Lee CC; Chen CY
Biomed Res Int; 2014; 2014():873010. PubMed ID: 25136636
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor.
Chen KB; Chen HY; Chen KC; Chen CY
Biomed Res Int; 2014; 2014():950191. PubMed ID: 25050380
[TBL] [Abstract][Full Text] [Related]
8. Insight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicine.
Hung TC; Lee WY; Chen KB; Chan YC; Chen CY
Biomed Res Int; 2014; 2014():871576. PubMed ID: 25045710
[TBL] [Abstract][Full Text] [Related]
9. Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers.
Lee WY; Chen KC; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():364625. PubMed ID: 24995286
[TBL] [Abstract][Full Text] [Related]
10. Identification and analyses of natural compounds as potential inhibitors of TRAF6-Basigin interactions in melanoma using structure-based virtual screening and molecular dynamics simulations.
Biswas R; Chowdhury N; Mukherjee R; Bagchi A
J Mol Graph Model; 2018 Oct; 85():281-293. PubMed ID: 30253283
[TBL] [Abstract][Full Text] [Related]
11. Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study.
Tsou YA; Chen KC; Lin HC; Chang SS; Chen CY
PLoS One; 2012; 7(11):e50087. PubMed ID: 23209648
[TBL] [Abstract][Full Text] [Related]
12. TRAF6 upregulates expression of HIF-1α and promotes tumor angiogenesis.
Sun H; Li XB; Meng Y; Fan L; Li M; Fang J
Cancer Res; 2013 Aug; 73(15):4950-9. PubMed ID: 23722539
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell endogenous HIF-1α activity induces aberrant angiogenesis and interacts with TRAF6 pathway required for colorectal cancer development.
Glaus Garzon JF; Pastrello C; Jurisica I; Hottiger MO; Wenger RH; Borsig L
Neoplasia; 2020 Dec; 22(12):745-758. PubMed ID: 33142239
[TBL] [Abstract][Full Text] [Related]
14. An investigation of small GTPases in relation to liver tumorigenesis using traditional Chinese medicine.
Hung TC; Lee WY; Chen KB; Chan YC; Chen CY
Biomed Res Int; 2014; 2014():428210. PubMed ID: 25045674
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TRAF6 alleviates choroidal neovascularization in vivo.
Ding D; Zhu M; Liu X; Jiang L; Xu J; Chen L; Liang J; Li L; Zhou T; Wang Y; Shi H; Yuan Y; Song E
Biochem Biophys Res Commun; 2018 Sep; 503(4):2742-2748. PubMed ID: 30103950
[TBL] [Abstract][Full Text] [Related]
16. Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.
Chen KC; Jian YR; Sun MF; Chang TT; Lee CC; Chen CY
J Biomol Struct Dyn; 2013; 31(11):1207-18. PubMed ID: 23075283
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis.
Wang W; Wan M; Liao D; Peng G; Xu X; Yin W; Guo G; Jiang F; Zhong W; He J
Biomed Res Int; 2017; 2017():4751780. PubMed ID: 29147652
[TBL] [Abstract][Full Text] [Related]
18. In silico investigation of potential SRC kinase ligands from traditional Chinese medicine.
Tou WI; Chen CY
PLoS One; 2012; 7(3):e33728. PubMed ID: 22470466
[TBL] [Abstract][Full Text] [Related]
19. Structure based virtual screening of natural products to disrupt the structural integrity of TRAF6 C-terminal domain homotrimer.
Biswas R; Chowdhury N; Biswas S; Roy R; Bagchi A
J Mol Graph Model; 2019 Dec; 93():107428. PubMed ID: 31493661
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and drug-likeness of anti-cancer traditional Chinese medicine: molecular docking and molecular dynamics simulation study.
Khan K; Albalawi K; Abbas MN; Burki S; Musad Saleh EA; Al Mouslem A; Alsaiari AA; A Zaki ME; Khan AU; Alotaibi G; Jalal K
J Biomol Struct Dyn; 2024 Apr; 42(7):3295-3306. PubMed ID: 37279114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
